BOUL Share Price Performance
SEK 0
-6.60 (-100.00%)
Price SEK 0
Fair ValueSEK 3.80
Share Pricen/a
Narrative Update • Jun 26
Boule Diagnostics AB (publ) Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
BOUL Community Narratives
AN
Fair Value
·Fair Value SEK 3.8 7.9% undervalued intrinsic discount
Decentralized Diagnostics And Recurring Consumables Revenue Will Drive Stronger Margins Ahead
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Decentralized Diagnostics And Recurring Consumables Revenue Will Drive Stronger Margins Ahead
Boule Diagnostics makes blood-testing machines and the consumables they use, and a big share of its sales comes from repeat purchases once those machines are installed. The key question is whether growing demand for testing closer to patients—and new product launches—can lift profitability despite currency swings and tougher competition.Read more
AN
SEK 3.8
7.9% undervalued intrinsic discount
Fair Value
Profit Margin
4.02%
Future PE
8.87x
Price in 2029
SEK 4.76
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
BOUL: Leadership Transition And Revised Forecasts Will Shape Balanced Outlook
Fair Value: SEK 3.8 7.9% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Boule Diagnostics AB (publ) Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Oct 23, 2026
- -0.071
- 42.99%
- -0.60%
- 107.3%
About BOUL
- Founded
- 1956
- Employees
- 200
- CEO
- WebsiteView website
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. It operates through Diagnostics and OEM Clinical Diagnostic Solutions. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, and Medonic brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics firms. The company was founded in 1956 and is headquartered in Spånga, Sweden.
